These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3474060)

  • 1. Differing patterns of human protooncogene expression in peripheral blood and bone marrow acute leukemia cells.
    Preisler HD; Sato H; Li YQ; Stein G; Stein J
    Cancer Res; 1987 Jul; 47(14):3747-51. PubMed ID: 3474060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the protooncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remission.
    Preisler HD; Kinniburgh AJ; Wei-Dong G; Khan S
    Cancer Res; 1987 Feb; 47(3):874-80. PubMed ID: 2433029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of minimal residual disease in acute myelogenous leukemia by RNA-in situ hybridization.
    Evinger-Hodges MJ; Spinolo JA; Spencer V; Nieto P; Dicke KA
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():13-5. PubMed ID: 2653488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protooncogene expression in subpopulations of cells from leukemia patients.
    Hulette BC; Banavali SD; Finke DP; Gopal V; Preisler HD
    Cytometry; 1992; 13(6):653-8. PubMed ID: 1451597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of growth-regulated genes in human acute leukemias.
    Ferrari S; Narni F; Mars W; Kaczmarek L; Venturelli D; Anderson B; Calabretta B
    Cancer Res; 1986 Oct; 46(10):5162-6. PubMed ID: 3756869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the proto-oncogenes c-sis, c-fos, c-myc and c-myb in acute myeloid leukemias.
    Strassburg CP; Neubauer V; Poliwoda H; Benter T
    Neoplasma; 1992; 39(6):343-7. PubMed ID: 1491723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-fos correlates with IFN-alpha responsiveness in Philadelphia chromosome positive chronic myelogenous leukemia.
    Eibl B; Greiter E; Grünewald K; Gastl G; Weyrer K; Thaler J; Aulitzky W; Herrmann F; Rapp U; Huber C
    Cytokines Mol Ther; 1995 Mar; 1(1):29-38. PubMed ID: 9384661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proto-oncogene expression in human normal bone marrow.
    Evinger-Hodges MJ; Dicke KA; Gutterman JU; Blick M
    Leukemia; 1987 Aug; 1(8):597-602. PubMed ID: 3669772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of growth-regulated protooncogenes in human malignant plasma cells.
    Palumbo AP; Pileri A; Dianzani U; Massaia M; Boccadoro M; Calabretta B
    Cancer Res; 1989 Sep; 49(17):4701-4. PubMed ID: 2667753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human peripheral blood granulocytes and myeloid leukemic cell lines express both transcripts encoding for stem cell factor.
    Ramenghi U; Ruggieri L; Dianzani I; Rosso C; Brizzi MF; Camaschella C; Pietsch T; Saglio G
    Stem Cells; 1994 Sep; 12(5):521-6. PubMed ID: 7528592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Kit receptor (CD117) expression on myeloblasts and white blood cell counts in acute myeloid leukemia.
    Woźniak J; Kopeć-Szlezak J
    Cytometry B Clin Cytom; 2004 Mar; 58(1):9-16. PubMed ID: 14994370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing patterns of proto-oncogene expression in immature and mature myeloid cells.
    Preisler HD; Guan WD; Khan S; Kinniburgh A
    Leuk Res; 1987; 11(10):923-34. PubMed ID: 2446085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells.
    Abbaszadegan MR; Futscher BW; Klimecki WT; List A; Dalton WS
    Cancer Res; 1994 Sep; 54(17):4676-9. PubMed ID: 8062263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
    Curran T; Bravo R; Müller R
    Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
    Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
    Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic cell colony formation in soft agar by bone marrow cells and peripheral blood cells from untreated acute leukemia patients.
    Dicke KA; Tindle SE; Davis FM; Jagannath S; Tucker S; Lilien M; van Leeuwen P; Verma DS; Vellekoop L
    Exp Hematol; 1983 Apr; 11(4):341-50. PubMed ID: 6341080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of oncogenes in human leukemias.
    McClain KL
    Cancer Res; 1984 Nov; 44(11):5382-9. PubMed ID: 6593118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. myc and sis expression in acute myelogenous leukemia.
    Evinger-Hodges MJ; Bresser J; Brouwer R; Cox I; Spitzer G; Dicke K
    Leukemia; 1988 Jan; 2(1):45-9. PubMed ID: 2448556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human blood.
    Popova EY; Claxton DF; Lukasova E; Bird PI; Grigoryev SA
    Exp Hematol; 2006 Apr; 34(4):453-62. PubMed ID: 16569592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.